vimarsana.com

TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need,

Related Keywords

Israel ,Barbara Lindheim ,Chemomab Therapeutics Ltd ,Strategic Communications ,Nasdaq ,Vice President ,Public Relations ,Region ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.